vs
Side-by-side financial comparison of BV Financial, Inc. (BVFL) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
BV Financial, Inc. is the larger business by last-quarter revenue ($10.5M vs $9.2M, roughly 1.1× Foghorn Therapeutics Inc.). BV Financial, Inc. runs the higher net margin — 45.6% vs -234.3%, a 279.9% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 9.2%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 11.1%).
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
BVFL vs FHTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.5M | $9.2M |
| Net Profit | $4.8M | $-21.7M |
| Gross Margin | — | — |
| Operating Margin | 66.9% | -258.2% |
| Net Margin | 45.6% | -234.3% |
| Revenue YoY | 9.2% | 223.8% |
| Net Profit YoY | 146.2% | -11.1% |
| EPS (diluted) | $0.52 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $10.5M | $9.2M | ||
| Q3 25 | $10.0M | $8.2M | ||
| Q2 25 | $9.9M | $7.6M | ||
| Q1 25 | $9.2M | $6.0M | ||
| Q4 24 | $9.7M | $2.9M | ||
| Q3 24 | $10.0M | $7.8M | ||
| Q2 24 | $9.5M | $6.9M | ||
| Q1 24 | $8.5M | $5.0M |
| Q4 25 | $4.8M | $-21.7M | ||
| Q3 25 | $3.7M | $-15.8M | ||
| Q2 25 | $2.9M | $-17.9M | ||
| Q1 25 | $2.1M | $-18.8M | ||
| Q4 24 | $2.0M | $-19.5M | ||
| Q3 24 | $3.8M | $-19.1M | ||
| Q2 24 | $3.4M | $-23.0M | ||
| Q1 24 | $2.6M | $-25.0M |
| Q4 25 | 66.9% | -258.2% | ||
| Q3 25 | 51.5% | -226.9% | ||
| Q2 25 | 39.9% | -279.2% | ||
| Q1 25 | 29.4% | -385.0% | ||
| Q4 24 | 29.5% | -840.5% | ||
| Q3 24 | 52.4% | -305.5% | ||
| Q2 24 | 49.6% | -386.6% | ||
| Q1 24 | 42.1% | -558.3% |
| Q4 25 | 45.6% | -234.3% | ||
| Q3 25 | 37.2% | -194.4% | ||
| Q2 25 | 29.0% | -237.3% | ||
| Q1 25 | 22.9% | -316.4% | ||
| Q4 24 | 20.2% | -682.9% | ||
| Q3 24 | 38.0% | -244.9% | ||
| Q2 24 | 35.8% | -333.6% | ||
| Q1 24 | 30.1% | -495.4% |
| Q4 25 | $0.52 | $-0.35 | ||
| Q3 25 | $0.41 | $-0.25 | ||
| Q2 25 | $0.29 | $-0.28 | ||
| Q1 25 | $0.21 | $-0.30 | ||
| Q4 24 | $0.18 | $-0.23 | ||
| Q3 24 | $0.35 | $-0.31 | ||
| Q2 24 | $0.32 | $-0.45 | ||
| Q1 24 | $0.24 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $55.7M | $80.9M |
| Total DebtLower is stronger | $35.0M | — |
| Stockholders' EquityBook value | $183.8M | $-108.5M |
| Total Assets | $912.2M | $198.1M |
| Debt / EquityLower = less leverage | 0.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.7M | $80.9M | ||
| Q3 25 | $63.5M | $89.3M | ||
| Q2 25 | $56.3M | $72.6M | ||
| Q1 25 | $70.8M | $61.0M | ||
| Q4 24 | $70.5M | $55.5M | ||
| Q3 24 | $94.1M | $57.7M | ||
| Q2 24 | $90.6M | $138.9M | ||
| Q1 24 | $78.8M | $79.3M |
| Q4 25 | $35.0M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $35.0M | — | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.9M | — | ||
| Q3 24 | $34.8M | — | ||
| Q2 24 | $34.8M | — | ||
| Q1 24 | $34.8M | — |
| Q4 25 | $183.8M | $-108.5M | ||
| Q3 25 | $190.2M | $-89.7M | ||
| Q2 25 | $198.0M | $-76.7M | ||
| Q1 25 | $198.1M | $-61.7M | ||
| Q4 24 | $195.5M | $-45.5M | ||
| Q3 24 | $209.7M | $-28.3M | ||
| Q2 24 | $205.5M | $-14.3M | ||
| Q1 24 | $201.8M | $-97.5M |
| Q4 25 | $912.2M | $198.1M | ||
| Q3 25 | $909.4M | $205.0M | ||
| Q2 25 | $908.3M | $226.2M | ||
| Q1 25 | $921.9M | $258.7M | ||
| Q4 24 | $911.8M | $284.0M | ||
| Q3 24 | $892.7M | $308.4M | ||
| Q2 24 | $897.2M | $328.6M | ||
| Q1 24 | $892.5M | $255.0M |
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.17× | — | ||
| Q2 24 | 0.17× | — | ||
| Q1 24 | 0.17× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.0M | $-22.3M |
| Free Cash FlowOCF − Capex | $18.8M | — |
| FCF MarginFCF / Revenue | 178.2% | — |
| Capex IntensityCapex / Revenue | 2.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 3.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.0M | $-22.3M | ||
| Q3 25 | $8.4M | $-18.9M | ||
| Q2 25 | $2.7M | $-21.0M | ||
| Q1 25 | $4.4M | $-24.0M | ||
| Q4 24 | $16.1M | $-24.5M | ||
| Q3 24 | $6.1M | $-21.0M | ||
| Q2 24 | $1.5M | $-25.5M | ||
| Q1 24 | $4.6M | $-29.3M |
| Q4 25 | $18.8M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $2.6M | $-21.0M | ||
| Q1 25 | $4.2M | $-24.0M | ||
| Q4 24 | $15.5M | $-25.0M | ||
| Q3 24 | $6.0M | $-21.3M | ||
| Q2 24 | $1.4M | $-25.6M | ||
| Q1 24 | $4.1M | $-29.4M |
| Q4 25 | 178.2% | — | ||
| Q3 25 | 84.0% | — | ||
| Q2 25 | 26.1% | -278.2% | ||
| Q1 25 | 46.0% | -403.2% | ||
| Q4 24 | 160.0% | -875.3% | ||
| Q3 24 | 59.6% | -273.0% | ||
| Q2 24 | 15.2% | -371.0% | ||
| Q1 24 | 48.4% | -583.1% |
| Q4 25 | 2.2% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 1.4% | 0.3% | ||
| Q1 25 | 2.4% | 0.5% | ||
| Q4 24 | 6.3% | 16.8% | ||
| Q3 24 | 1.0% | 4.0% | ||
| Q2 24 | 0.6% | 0.2% | ||
| Q1 24 | 5.1% | 2.0% |
| Q4 25 | 3.96× | — | ||
| Q3 25 | 2.26× | — | ||
| Q2 25 | 0.95× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | 8.23× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 0.44× | — | ||
| Q1 24 | 1.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
